For Alzheimer’s, Drugs Come More Slowly, but Tests on Horizon
Posted at 7 a.m. on July 25
The Economist magazine this week points out that efforts have slowed recently in developing drug treatment options for Alzheimer’s disease. However, the article highlights progress in developing tests to identify early indicators of Alzheimer’s.
Healthopolis last week noted a similar finding in a Thomson Reuters research group analysis of ongoing research that suggests that tests for Alzheimer’s could be in place by 2025.